FIBRICIN
FIBRICIN (Reteplase 18,1 mg )
Therapeutic indications
Fibricin is indicated for use in the management of acute myocardial infarction (AMI) in adults for the improvement of ventricular function following AMI, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with AMI.
Treatment should be initiated as soon as possible after the onset of AMI symptoms